Therapy for recurrent malignant glioma in adults

Maciej M. Mrugala, Santosh Kesari, Naren Ramakrishna, Patrick Y. Wen

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Malignant gliomas are the most common form of primary brain tumors in adults. Although the prognosis remains poor, there has been recent progress in the treatment of these tumors. Standard therapy for patients with this disease will be reviewed, together with more novel approaches such as targeted molecular therapies, angiogenesis inhibitors, immunotherapies, gene therapies and intratumoral therapies.

Original languageEnglish (US)
Pages (from-to)759-782
Number of pages24
JournalExpert review of anticancer therapy
Issue number5
StatePublished - Oct 2004


  • Angiogenesis
  • Chemotherapy
  • Gene therapy
  • Immunotherapy
  • Malignant glioma
  • Radiation therapy
  • Targeted molecular therapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Therapy for recurrent malignant glioma in adults'. Together they form a unique fingerprint.

Cite this